Nevro Announces Executive Appointments

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

Nevro Corp. (NYSE: NVRO) today announced the appointments of two senior executives to the Company’s leadership team. Ms. Niamh Pellegrini has been named Chief Commercial Officer, responsible for all global sales and marketing-related activities, and Ms. Lori Ciano has been named Chief Human Resources Officer.  Ms. Pellegrini and Ms. Ciano will report directly to D. Keith Grossman, Chairman, CEO and President.

“We are excited to have such proven and experienced professionals join the Nevro executive team to lead two of our highest priorities – serving our customers and our people.  Niamh will lead and coordinate the efforts of our talented commercial leadership team in order to execute our commercial strategies and drive sales growth.  Lori will work to develop our organizational structure, talent development and performance management systems, while at the same time, preserving our award-winning culture,” said D. Keith Grossman, CEO and President of Nevro.

Niamh Pellegrini is a proven commercial leader with 20 years of experience in the healthcare industry.  Prior to joining Nevro, Ms. Pellegrini was Vice President of Global Commercial Operations for Abbott Vascular, where she was responsible for driving approximately $3B in revenue.  Prior to Abbott, Ms. Pellegrini served as CEO and President at Autonomic Technologies, Inc., where she led a turnaround of its European commercial business and drove U.S. market access.  Previously, Ms. Pellegrini was President, North America at Thoratec Corporation, where she helped return the company to growth prior to its acquisition.  Prior to joining Thoratec Corporation, Ms. Pellegrini served in progressively responsible global business development, strategy and commercial roles at Johnson & Johnson.  Niamh Pellegrini graduated from Santa Clara University with an M.B.A and a B.S. in finance.

Lori Ciano brings more than 15 years of experience as a senior human resources leader in both the life sciences and technology industries.  Prior to joining Nevro, Ms. Ciano was Senior Vice President, Human Resources at Dermira, a Menlo Park-based biotechnology company.  Prior to Dermira, Lori served as Vice President of Information Technology and Chief Human Resources Officer at Thoratec Corporation leading up to the company’s acquisition.  Ms. Ciano has also led HR organizations at Conceptus, Affymetrix, and Novellus Systems.  She began her career at Varian where she served in marketing and business development roles.  Lori Ciano earned an M.S. in psychology from JFK University, an M.B.A. from Santa Clara University, and a B.S. in marketing from San José State University.



Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.